Ornade

combination of chlorpheniramine, phenylpropanolamine and isopropamide iodide

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Stress Urinary Incontinence 08/01/1979 - "Urethral pressure profilometry was done on 12 women with stress urinary incontinence and in 6 women with no history of incontinence, before and 1 to 2 hours after the administration of Ornade. " 08/01/1979 - "Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence." 08/01/1979 - "It is believed that the phenylpropanolamine component of Ornade stimulates alpha-adrenergic receptors at the vesical neck and in the proximal urethra to achieve the therapeutic effect of reducing or eliminating stress urinary incontinence. " 05/01/1976 - "There were 77 women with mild to moderate stress urinary incontinence treated with the sympathomimetic agent, phenylpropanolamine hydrochloride, combined with chlorpheniramine maleate and isopropamide iodide in a sustained release capsule (Ornade). "
2.	Nocturnal Enuresis (Bedwetting) 01/01/1984 - "Phenylpropanolamine (Ornade), 25-50 mg at bedtime, stabilizes the vesicosphincteric unit and stopped bedwetting in 11 of 16 patients."
3.	Hypertension (High Blood Pressure) 01/01/1974 - "Ornade and anticholinergic toxicity: hypertension, hallucinations, and arrhythmias."
4.	Hallucinations (Hallucination) 01/01/1974 - "Ornade and anticholinergic toxicity: hypertension, hallucinations, and arrhythmias."

1.	Phenylpropanolamine (Dexatrim)
2.	Therapeutic Uses
3.	Cholinergic Antagonists (Anticholinergics)
4.	Sympathomimetics (Sympathomimetic Amines)
5.	alpha Adrenergic Receptors
6.	Chlorpheniramine (Chlorphenamine)
7.	Capsules (Microcapsules)
8.	isopropamide iodide